SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-029620
Filing Date
2023-06-13
Accepted
2023-06-13 16:41:19
Documents
12
Period of Report
2023-06-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K brhc20054391_8k.htm   iXBRL 8-K 25579
  Complete submission text file 0001140361-23-029620.txt   165728

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avro-20230612.xsd EX-101.SCH 3862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20230612_lab.xml EX-101.LAB 23290
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20230612_pre.xml EX-101.PRE 16550
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc20054391_8k_htm.xml XML 4383
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 231011748
SIC: 2836 Biological Products, (No Diagnostic Substances)